• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    40 Stocks Moving In Wednesday's Mid-Day Session

    6/22/22 12:17:03 PM ET
    $ATHA
    $AXU
    $BHAT
    $BORR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Recreational Games/Products/Toys
    Consumer Discretionary
    Get the next $ATHA alert in real time by email

     

    Gainers

    • Ocean Bio-Chem, Inc. (NASDAQ:OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
    • Revlon, Inc. (NYSE:REV) surged 47% to $8.91 on continued volatility following the company's recent bankruptcy filing. The stock has also been circulated as a short squeeze candidate.
    • JX Luxventure Limited (NASDAQ:LLL) gained 39.2% to $2.0750. JX Luxventure announced a $5 million buyback and also signed a $30 million sales agreement.
    • U.S. Well Services, Inc. (NASDAQ:USWS) rose 35.1% to $0.9711 after ProFrac Holding Corp. (NASDAQ:PFHC) announced plans to acquire the company for $1.21 per share in an all-stock deal.
    • Exela Technologies, Inc. (NASDAQ:XELA) gained 32.4% to $0.1804 after the company announced a new customer win of $136 million in total contract value.
    • Phoenix Motor Inc. (NASDAQ:PEV) gained 31.6% to $4.50.
    • 22nd Century Group, Inc. (NASDAQ:XXII) surged 27.9% to $2.0850. The FDA has cleared Juul rivals to keep tobacco-flavored e-cigarettes on the market, according to Dow Jones.
    • Boxed, Inc. (NYSE:BOXD) jumped 26% to $2.0300.
    • Quotient Limited (NASDAQ:QTNT) rose 24.1% to $0.4636. Quotient said it expects to report reagent business generated product sales of $9.8m in the fourth quarter of Fiscal 2022. The company also sees FY22 revenue of $38.5 million.
    • Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) surged 23.7% to $33.91.
    • Medicenna Therapeutics Corp. (NASDAQ:MDNA) jumped 22.7% to $1.03 after reporting fiscal year 2022 results.
    • Worksport Ltd. (NASDAQ:WKSP) jumped 20.7% to $2.2571 after the company launched storefronts on Amazon, eBay and Walmart Marketplace.
    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) gained 18.3% to $0.7337 on abnormally-high volume.
    • Sorrento Therapeutics, Inc. (NASDAQ:SRNE) gained 17.7% to $2.4485.
    • Wave Life Sciences Ltd. (NASDAQ:WVE) shares gained 17% to $2.41. Wave Life Sciences recently announced pricing of $70.0 million underwritten offering.
    • Invitae Corporation (NYSE:NVTA) jumped 15.8% to $2.62.
    • RedHill Biopharma Ltd. (NASDAQ:RDHL) gained 15.5% to $0.78. RedHill Biopharma was granted U.S. Patent #11,364,227 Sphingosine kinase 2 inhibitor for treating coronavirus infection.
    • Aclarion, Inc. (NASDAQ:ACON) jumped 15.5% to $0.94.
    • TScan Therapeutics, Inc. (NASDAQ:TCRX) gained 15% to $3.2650.
    • Codex DNA, Inc. (NASDAQ:DNAY) rose 14.3% to $2.4450 after declining 10% on Tuesday.
    • Epizyme, Inc. (NASDAQ:EPZM) jumped 13.2% to $0.8995.
    • Precision BioSciences, Inc. (NASDAQ:DTIL) shares rose 12.5% to $1.5650 as the company reported a $50 million offering of common stock and announced in vivo gene editing collaboration with Novartis to develop potentially curative treatment for disorders including sickle cell disease.
    • F-star Therapeutics, Inc. (NASDAQ:FSTX) jumped 11.7% to $4.00.
    • Talkspace, Inc. (NASDAQ:TALK) gained 7% to $1.69.
    • La-Z-Boy Incorporated (NYSE:LZB) rose 5% to $23.85 after the company reported upbeat results for its fourth quarter and issued strong sales forecast for the first quarter.

     

     

    Losers

    • Athira Pharma, Inc. (NASDAQ:ATHA) shares tumbled 66.8% to $2.8038 after the company reported that the primary endpoint of change in biomarker ERP P300 latency was not statistically significant from its exploratory ACT-AD Phase 2 study of fosgonimeton.
    • Alexco Resource Corp. (NYSE:AXU) dipped 34.8% to $0.5276.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) fell 32.4% to $1.96 after the company announced a $5 million registered direct offering.
    • Electric Last Mile Solutions, Inc. (NASDAQ:ELMS) dipped 17.9% to $0.2378.
    • Micro Focus International plc (NYSE:MFGP) fell 16.6% to $3.5950.
    • ProFrac Holding Corp. (NASDAQ:PFHC) declined 13.5% to $18.59. ProFrac Holding announced plans to acquire U.S. Well Services for $1.21 per share in an all-stock deal.
    • Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) dropped 13.1% to $1.7115. Kaival Brands recently reached an agreement with Phillip Morris for international electronic nicotine delivery system product distribution.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) fell 13% to $0.8350.
    • 4D pharma plc (NASDAQ:LBPS) declined 12.5% to $1.54.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) dropped 11% to $10.32.
    • Tellurian Inc. (NASDAQ:TELL) declined 10.2% to $3.3050.
    • Borr Drilling Limited (NYSE:BORR) shares fell 9.5% to $5.51 following a 10% surge on Tuesday.
    • IMV Inc. (NASDAQ:IMV) fell 8.9% to $0.6598. IMV reported a $10 million drawdown from its existing long-term debt facility.
    • Centennial Resource Development, Inc. (NASDAQ:CDEV) fell 7% to $6.91.
    • AgEagle Aerial Systems, Inc. (NYSE:UAVS) fell 6% to $0.7252. AgEagle Aerial Systems shares jumped 33% on Tuesday after the company announced the European Union Aviation Safety Agency issued a Design Verification Report (DVR) establishing that the eBee X meets Ground Risk Class M2 mitigation qualifications.

     

    Get the next $ATHA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATHA
    $AXU
    $BHAT
    $BORR

    CompanyDatePrice TargetRatingAnalyst
    Wave Life Sciences Ltd.
    $WVE
    2/5/2026$38.00Buy
    BofA Securities
    Wave Life Sciences Ltd.
    $WVE
    12/12/2025$20.00 → $33.00Outperform
    Wedbush
    Talkspace Inc.
    $TALK
    12/9/2025$3.50Equal Weight
    Barclays
    Wave Life Sciences Ltd.
    $WVE
    12/9/2025$27.00Sector Perform → Outperform
    RBC Capital Mkts
    La-Z-Boy Incorporated
    $LZB
    11/19/2025$39.00Neutral → Buy
    Sidoti
    TScan Therapeutics Inc.
    $TCRX
    11/14/2025Overweight → Equal-Weight
    Morgan Stanley
    Talkspace Inc.
    $TALK
    10/31/2025$5.00Hold → Buy
    Needham
    Wave Life Sciences Ltd.
    $WVE
    10/20/2025$18.00Overweight
    Wells Fargo
    More analyst ratings

    $ATHA
    $AXU
    $BHAT
    $BORR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TAZVERIK issued to EPIZYME INC

    Submission status for EPIZYME INC's drug TAZVERIK (SUPPL-5) with active ingredient TAZEMETOSTAT HYDROBROMIDE has changed to 'Approval' on 08/13/2024. Application Category: NDA, Application Number: 211723, Application Classification: Labeling

    8/14/24 4:43:30 AM ET
    $EPZM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TAZVERIK issued to EPIZYME INC

    Submission status for EPIZYME INC's drug TAZVERIK (SUPPL-4) with active ingredient TAZEMETOSTAT HYDROBROMIDE has changed to 'Approval' on 11/16/2023. Application Category: NDA, Application Number: 211723, Application Classification: Labeling

    11/17/23 4:37:35 AM ET
    $EPZM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ATHA
    $AXU
    $BHAT
    $BORR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    Precision BioSciences, Inc. (NASDAQ:DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that, on April 20, 2026, the Compensation Committee of Precision's Board of Directors approved the grant of an inducement award of 7,094 restricted stock units ("RSUs") to a new employee under the Precision BioSciences, Inc. 2021 Employment Inducement Incentive Award Plan ("Inducement Award Plan") in connection with their commencement of employment. The award was granted under Nasdaq Listing Rule 5635(c)(4) as an inducement for the employee to commence service with Precision.

    4/24/26 7:01:00 AM ET
    $DTIL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    A $550 Billion Opportunity: Drones-as-a-Service Emerges as Defense's Next Growth Engine

    Governments are accelerating investments in scalable autonomous drone operations without the burden of fleet ownershipMarket News Updates News Commentary CounterNEW YORK, April 23, 2026 /CNW/ -- Drones-as-a-Service (DaaS) is quickly becoming a major shift in how military and defense organizations actually use drone technology in the field. Instead of spending heavily to purchase and maintain their own fleets, agencies can now tap into drone capabilities like aerial surveillance, mapping, logistics delivery, and ISR (intelligence, surveillance, and reconnaissance) whenever they're needed. It works a lot like a cloud subscription model—giving operators access to the latest hardware, AI-powered

    4/23/26 9:00:00 AM ET
    $PRZO
    $RCAT
    $UAVS
    Military/Government/Technical
    Industrials
    Computer Software: Prepackaged Software
    Technology

    22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University

    MOCKSVILLE, N.C., April 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on nicotine reduction and plant biotechnology, today announced corporate updates regarding a new testing services agreement with North Carolina State University aimed at validating tobacco varieties featuring improved leaf quality and increased crop yields with the same low-nicotine content. The initiative builds upon 22nd Century's proprietary reduced nicotine content technology platform, which utilizes advanced plant breeding and biotechnology to reduce nicotine content in tobacco to minimally addictive levels. The Company's reduced nicotine tobacco is the foun

    4/23/26 7:50:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ATHA
    $AXU
    $BHAT
    $BORR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities initiated coverage on Wave Life Sciences with a new price target

    BofA Securities initiated coverage of Wave Life Sciences with a rating of Buy and set a new price target of $38.00

    2/5/26 9:31:24 AM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wedbush reiterated coverage on Wave Life Sciences with a new price target

    Wedbush reiterated coverage of Wave Life Sciences with a rating of Outperform and set a new price target of $33.00 from $20.00 previously

    12/12/25 8:29:31 AM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barclays initiated coverage on Talkspace with a new price target

    Barclays initiated coverage of Talkspace with a rating of Equal Weight and set a new price target of $3.50

    12/9/25 8:53:40 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $ATHA
    $AXU
    $BHAT
    $BORR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Lynx1 Capital Management Lp bought $73,552 worth of shares (81,732 units at $0.90) and bought $71,974 worth of shares (80,069 units at $0.90) (SEC Form 4)

    4 - TScan Therapeutics, Inc. (0001783328) (Issuer)

    12/23/25 6:17:28 PM ET
    $TCRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Germano Geno J bought $14,160 worth of shares (3,000 units at $4.72), increasing direct ownership by 14% to 23,883 units (SEC Form 4)

    4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)

    12/17/25 7:02:05 AM ET
    $DTIL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Frankel Stanley bought $12,690 worth of shares (2,700 units at $4.70), increasing direct ownership by 16% to 19,478 units (SEC Form 4)

    4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)

    12/17/25 7:01:09 AM ET
    $DTIL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ATHA
    $AXU
    $BHAT
    $BORR
    SEC Filings

    View All

    SEC Form 6-K filed by Redhill Biopharma Ltd.

    6-K - RedHill Biopharma Ltd. (0001553846) (Filer)

    4/22/26 8:02:19 AM ET
    $RDHL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by Wave Life Sciences Ltd.

    DEFA14A - Wave Life Sciences Ltd. (0001631574) (Filer)

    4/21/26 5:05:21 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 8-K filed by Wave Life Sciences Ltd.

    8-K - Wave Life Sciences Ltd. (0001631574) (Filer)

    4/21/26 4:49:30 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATHA
    $AXU
    $BHAT
    $BORR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Raday Gilead

    4 - RedHill Biopharma Ltd. (0001553846) (Issuer)

    4/22/26 6:09:14 PM ET
    $RDHL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Wright Christopher I

    3 - Wave Life Sciences Ltd. (0001631574) (Issuer)

    4/17/26 9:00:05 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Ingelsson Erik

    3 - Wave Life Sciences Ltd. (0001631574) (Issuer)

    4/17/26 9:00:03 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATHA
    $AXU
    $BHAT
    $BORR
    Leadership Updates

    Live Leadership Updates

    View All

    Military UAV Sector Forecast to Surpass $40+ Billion as Modern Warfare Evolves

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Unmanned aerial vehicles (UAVs), commonly known as drones, have become a transformative technology in modern defense and military operations, reshaping strategies from reconnaissance to precision strike capabilities. Military drones offer armed forces enhanced situational awareness, reduced risk to personnel, and cost-efficient mission profiles across surveillance, target acquisition, logistics, and electronic warfare. As autonomous systems incorporating artificial intelligence and advanced sensor suites continue to mature, they are increasingly integral to networked battlefield operations and force multiplie

    2/19/26 8:30:00 AM ET
    $NOC
    $PRZO
    $UAVS
    Industrial Machinery/Components
    Industrials
    Military/Government/Technical
    Aerospace

    William Boor Elected to La-Z-Boy Incorporated's Board of Directors

    MONROE, Mich., Dec. 09, 2025 (GLOBE NEWSWIRE) -- La-Z-Boy Incorporated (NYSE:LZB), a global leader in the retail and manufacture of residential furniture, today announced that William (Bill) Boor has joined the company's Board of Directors, effective December 8, 2025. "We are pleased to welcome Bill to our Board of Directors and look forward to his insights and contributions," said Melinda Whittington, Board Chair, President and Chief Executive Officer. "With a long history of service as both a public company CEO and an independent director, Bill has a proven track record of driving transformational growth, strong governance, and servant leadership. These skillsets, combined with his expe

    12/9/25 4:15:00 PM ET
    $LZB
    Home Furnishings
    Consumer Discretionary

    Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points

    Issued on behalf of GT Biopharma, Inc. USA News Group News Commentary VANCOUVER, BC, Dec. 4, 2025 /PRNewswire/ -- Triple-therapy immunotherapy approaches are demonstrating complete leukemia elimination in preclinical models by reprogramming how cancer cells die to trigger powerful immune responses[1], while breakthrough natural killer cell research is revealing new pathways to supercharge the body's innate tumor-fighting capabilities[2]. These developments position GT Biopharma, Inc. (NASDAQ:GTBP), Geron Corporation (NASDAQ:GERN), Kura Oncology, Inc. (NASDAQ:KURA), SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), and TScan Therapeutics, Inc. (NASDAQ:TCRX). The FDA's November approval of the f

    12/4/25 12:20:00 PM ET
    $GERN
    $GTBP
    $KURA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    $ATHA
    $AXU
    $BHAT
    $BORR
    Financials

    Live finance-specific insights

    View All

    Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026

    CAMBRIDGE, Mass., April 22, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ:WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Tuesday, April 28, 2026, to review the company's first quarter 2026 financial results and provide business updates. The webcast and conference call may be accessed by visiting "Investor Events" on the investors section of the Wave Life Sciences website: https://ir.wavelifesciences.com/events-publications/events. Analysts planning to participate during the Q&A portion of the live call can join the conference call a

    4/22/26 8:30:00 AM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    La-Z-Boy Incorporated Announces Sale of American Drew and Kincaid Wholesale Casegoods Businesses

    Key Highlights: American Drew and Kincaid wholesale casegoods businesses to be sold to Banner House (formerly Magnussen Home Furnishings, Inc.), a multi-branded portfolio of home furnitureTransaction is scheduled to close in mid-MayLa-Z-Boy will continue to offer casegoods products in its 374 stores across North America as part of its whole home solution for consumersSeamless transition expected for existing customers, dealers, and suppliersTransaction advances La-Z-Boy Incorporated progress of focusing on its core, vertically integrated North American upholstery business MONROE, Mich., April 21, 2026 (GLOBE NEWSWIRE) -- La-Z-Boy Incorporated (NYSE:LZB), a global leader in the retail and

    4/21/26 4:15:00 PM ET
    $LZB
    Home Furnishings
    Consumer Discretionary

    La-Z-Boy Incorporated Introduces AudioLuxe, a New Premium Audio Furniture Line with Sound by Klipsch

    Key Highlights: New AudioLuxe by La-Z-Boy® premium audio furniture line debuts at High Point Market with select availability this fallThe product line combines an integrated audio experience with the comfort and quality for which La-Z-Boy is knownKey features, driven by consumer led insights, include Sound by Klipsch, surround sound with audio-visual sync, Auracast™ Bluetooth audio sharing, personalized controls, and La-Z-Boy customizable comfort MONROE, Mich., April 20, 2026 (GLOBE NEWSWIRE) -- La-Z-Boy Incorporated (NYSE:LZB), a global leader in the retail and manufacture of residential furniture, is bringing premium audio to its motion furniture lineup with the debut of AudioLuxe by

    4/20/26 9:15:00 AM ET
    $GNTX
    $LZB
    Auto Parts:O.E.M.
    Consumer Discretionary
    Home Furnishings

    $ATHA
    $AXU
    $BHAT
    $BORR
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at Athira Pharma Inc. on Jun 25

    Recently, on June 25, 2024, Director Romano Kelly A bought $100,051 worth of shares in Athira Pharma Inc. This transaction involved acquiring 42,400 units at $2.36 per share, resulting in a significant increase in direct ownership by 111% to 80,715 units. The purchase was disclosed in the SEC Form 4 filing. Insider buying is often considered a bullish signal as insiders may have insights into the company's future performance. It's essential to analyze this insider purchase in conjunction with previous insider transactions to identify any patterns or trends. Taking into account the information from the SEC filings, several other insiders at Athira Pharma Inc. have also been active in the sto

    6/26/24 3:07:15 PM ET
    $ATHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ATHA
    $AXU
    $BHAT
    $BORR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Exela Technologies Inc.

    SC 13D/A - Exela Technologies, Inc. (0001620179) (Subject)

    12/3/24 4:01:40 PM ET
    $XELA
    Business Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care